{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:08:02Z","timestamp":1791144482495,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bioactmat.2024.10.015","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T01:46:06Z","timestamp":1729561566000},"page":"236-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Preventing postsurgical colorectal cancer relapse: A hemostatic hydrogel loaded with METTL3 inhibitor for CAR-NK cell therapy"],"prefix":"10.1016","volume":"44","author":[{"given":"Zilin","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-8885","authenticated-orcid":false,"given":"Kexin","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuofei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4122-0861","authenticated-orcid":false,"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2024.10.015_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib2","first-page":"1","article-title":"Management of colorectal cancer","volume":"366","author":"Brown","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib3","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2018.5816","article-title":"Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer","volume":"319","author":"Snyder","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib5","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/annonc\/mds236","article-title":"ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making","volume":"23","author":"Schmoll","year":"2012","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib6","article-title":"Colorectal cancer","volume":"1","author":"Kuipers","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/2159-8290.CD-20-0556","article-title":"Outlook for new CAR-based therapies with a focus on CAR NK cells: what lies beyond CAR-engineered T cells in the race against cancer","volume":"11","author":"Daher","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ymthe.2019.03.011","article-title":"Adoptive transfer of NKG2D CAR mRNA-engineered natural killer cells in colorectal cancer patients","volume":"27","author":"Xiao","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13045-021-01083-5","article-title":"Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy","volume":"14","author":"Gong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.stemcr.2014.01.014","article-title":"Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells","volume":"2","author":"Valamehr","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.stem.2018.06.002","article-title":"Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2341","article-title":"Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia","volume":"8","author":"Romee","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003894","article-title":"Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities","volume":"9","author":"Christodoulou","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-021-00537-w","article-title":"NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma","volume":"11","author":"Leivas","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3389\/fimmu.2020.01242","article-title":"Prognostic significance of tumor-infiltrating natural killer cells in solid tumors: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.05.002","article-title":"IFN-\u0393: a cytokine at the right time, is in the right place","volume":"43","author":"Burke","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104514","article-title":"m(6) A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy","volume":"39","author":"Wang","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-020-00895-1","article-title":"Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-022-01634-5","article-title":"The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer","volume":"21","author":"Shi","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib20","article-title":"Progress and prospect of nanotechnology for cardiac fibrosis treatment","volume":"1","author":"Gaytan","year":"2023","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib21","first-page":"1","article-title":"Tumor-microenvironment-activatable polymer nano-immunomodulator for precision cancer photoimmunotherapy","volume":"34","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adma.202370152","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1pd-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib23","article-title":"Engineering multifunctional adhesive hydrogel patches for biomedical applications","volume":"1","author":"Chakraborty","year":"2023","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib24","first-page":"1","article-title":"A physiologically responsive nanocomposite hydrogel for treatment of head and neck squamous cell carcinoma via proteolysis-targeting chimeras enhanced immunotherapy","volume":"35","author":"Wu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib25","article-title":"An injectable epigenetic autophagic modulatory hydrogel for boosting umbilical cord blood NK cell therapy prevents postsurgical relapse of triple-negative breast cancer","volume":"9","author":"Gong","year":"2022","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Ger."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121506","article-title":"Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma","volume":"284","author":"Cheng","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13287-021-02251-7","article-title":"Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy","volume":"12","author":"Marofi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5966\/sctm.2012-0084","article-title":"Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy","volume":"2","author":"Knorr","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nprot.2008.42","article-title":"A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies","volume":"3","author":"Ng","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib30","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1182\/blood-2013-10-532531","article-title":"Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein","volume":"123","author":"Bachanova","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-62703-478-4_3","article-title":"Hematopoietic and nature killer cell development from human pluripotent stem cells","volume":"1029","author":"Ni","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib32","first-page":"890","article-title":"Hybrid gelatin\/oxidized chondroitin sulfate hydrogels incorporating bioactive glass nanoparticles with enhanced mechanical properties, mineralization, and osteogenic differentiation","volume":"6","author":"Zhou","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib33","first-page":"1","article-title":"Injectable self-healing natural biopolymer-based hydrogel adhesive with thermoresponsive reversible adhesion for minimally invasive surgery","volume":"31","author":"Zhou","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202101356","article-title":"An integrated strategy for rapid hemostasis during tumor resection and prevention of postoperative tumor recurrence of hepatocellular carcinoma by antibacterial shape memory cryogel","volume":"17","author":"Liang","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adma.202001628","article-title":"An adhesive hydrogel with \u201cload-sharing\u201d effect as tissue bandages for drug and cell delivery","volume":"32","author":"Chen","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.aaz4204","article-title":"Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses","volume":"6","author":"Chao","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym12020501","article-title":"Gelatin methacryloyl hydrogels control the localized delivery of albumin-bound paclitaxel","volume":"12","author":"Vigata","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib39","article-title":"METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy., Cell Reports","volume":"4","author":"Pan","year":"2023","journal-title":"Med."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/aps.2017.125","article-title":"Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy","volume":"39","author":"Hu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/scbi.1998.0119","article-title":"The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues","volume":"9","author":"Hammarstr\u00f6m","year":"1999","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib42","first-page":"1962","article-title":"124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice","volume":"44","author":"Sundaresan","year":"2003","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib43","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1158\/1078-0432.CCR-15-1696","article-title":"A novel carcinoembryonic antigen T-cell bispecific antibody (CEA TCB) for the treatment of solid tumors","volume":"22","author":"Bacac","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-019-1038-7","article-title":"METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-021-02227-8","article-title":"METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis","volume":"41","author":"Pan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib46","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","article-title":"RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 Axis and is a therapeutic target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib47","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s13046-019-1408-4","article-title":"Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246\/SPRED2\/MAPK signaling pathway","volume":"38","author":"Peng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.115858","article-title":"pH-Responsive nanoparticles based on cholesterol\/imidazole modified oxidized-starch for targeted anticancer drug delivery","volume":"233","author":"Xu","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib49","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/s41388-022-02185-1","article-title":"METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner","volume":"41","author":"Xu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111530","article-title":"METTL3 regulates m(6)A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma","volume":"41","author":"Zhang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib51","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","article-title":"METTL3 inhibits antitumor immunity by targeting m(6)a-BHLHE41-CXCL1\/CXCR2 Axis to promote colorectal cancer","volume":"163","author":"Chen","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioactmat.2024.10.015_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adma.202004559","article-title":"Biopolymer immune implants' sequential activation of innate and adaptive immunity for colorectal cancer postoperative immunotherapy","volume":"33","author":"Ji","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.10.015_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.202100862","article-title":"In\u2013situ-sprayed dual-functional immunotherapeutic gel for colorectal cancer postsurgical treatment","volume":"10","author":"Si","year":"2021","journal-title":"Adv. Healthc. Mater."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24004602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24004602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T05:51:27Z","timestamp":1735537887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X24004602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"alternative-id":["S2452199X24004602"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.10.015","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing postsurgical colorectal cancer relapse: A hemostatic hydrogel loaded with METTL3 inhibitor for CAR-NK cell therapy","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}